As shown in our schematic diagram of signaling pathways (Supplementary Figure S4), BTZ induces caspase cleavage and apoptosis of MM cells, resulting in drug sensitivity to BTZ treatment. This evidence concerns the gene CASC3 and Miyoshi myopathy.